Details
Stereochemistry | RACEMIC |
Molecular Formula | C17H20N4O.ClH |
Molecular Weight | 332.828 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CC(CN1C2=C(NC3=C(C=CC=N3)C1=O)C=CC=C2)N(C)C
InChI
InChIKey=DNZVNKSQOUOBOY-UHFFFAOYSA-N
InChI=1S/C17H20N4O.ClH/c1-12(20(2)3)11-21-15-9-5-4-8-14(15)19-16-13(17(21)22)7-6-10-18-16;/h4-10,12H,11H2,1-3H3,(H,18,19);1H
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C17H20N4O |
Molecular Weight | 296.3669 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Effects of long-term treatment of rats with antidepressants on adrenergic-receptor sensitivity in cerebral cortex: Structure activity study. | 1983 |
|
Effects of JL13, a pyridobenzoxazepine with potential atypical antipsychotic activity, in animal models for schizophrenia. | 2001 Jul |
|
Recent advances in the solid-phase combinatorial synthetic strategies for the benzodiazepine based privileged structures. | 2006 Jan |
|
Method development for a pyridobenzodiazepine library with multiple diversification points. | 2008 Mar-Apr |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 08:58:04 GMT 2023
by
admin
on
Sat Dec 16 08:58:04 GMT 2023
|
Record UNII |
Z5MO8L6XHR
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
Z5MO8L6XHR
Created by
admin on Sat Dec 16 08:58:04 GMT 2023 , Edited by admin on Sat Dec 16 08:58:04 GMT 2023
|
PRIMARY | |||
|
m9216
Created by
admin on Sat Dec 16 08:58:04 GMT 2023 , Edited by admin on Sat Dec 16 08:58:04 GMT 2023
|
PRIMARY | Merck Index | ||
|
14559-79-6
Created by
admin on Sat Dec 16 08:58:04 GMT 2023 , Edited by admin on Sat Dec 16 08:58:04 GMT 2023
|
PRIMARY | |||
|
3082068
Created by
admin on Sat Dec 16 08:58:04 GMT 2023 , Edited by admin on Sat Dec 16 08:58:04 GMT 2023
|
PRIMARY | |||
|
DTXSID30932648
Created by
admin on Sat Dec 16 08:58:04 GMT 2023 , Edited by admin on Sat Dec 16 08:58:04 GMT 2023
|
PRIMARY | |||
|
238-603-8
Created by
admin on Sat Dec 16 08:58:04 GMT 2023 , Edited by admin on Sat Dec 16 08:58:04 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |